Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-28 @ 10:04 AM
Study NCT ID:
NCT02247869
Status:
COMPLETED
Last Update Posted:
2018-02-09
First Post:
2014-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma
Sponsor:
Fondazione Italiana Linfomi - ETS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-07
First Submit QC Date:
None
Study First Post Date:
2014-09-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-08
Last Update Post Date:
2018-02-09
Last Update Post Date Type:
ACTUAL